2.4.4. Exclusion criteria.
allergic, ovarian endometriosis cyst, uterine abnormalities, endometrial polyps).Women, uterine appendage abnormalities, ovarian absence, adenomyosis, bicornuate
SPONTANEOUS ABORTIONS, ADENOMYOSIS, HYDROSALPINX, RECURRENT SPONTANEOUS ABORTION, UTERUS
Women with any of the following exclusion criteria are not eligible to participate in the study:Women aged ≥ 43 years.Women with body mass index ≥35 kg/mWomen undergoing oocyte donor cycle.Women with a history of recurrent spontaneous abortion or repeated implantation failure, defined as 2 or more spontaneous abortions or failed IVF-ET attempts.Women undergoing a cycle of In vitro Maturation or Preimplantation Genetic Testing.Women with uterine abnormalities, congenital (e.g., bicornuate uterus) or acquired (e.g., severe adenomyosis and multiple endometrial polyps).Women with uterine appendage abnormalities (e.g., non-surgically treated hydrosalpinx and ovarian endometriosis cyst requiring surgery).Unilateral ovarian absence.Women allergic to or intolerant of EZTG or other medications applied in the study.